Clinical trial
A Randomized, Triple-blind Placebo-controlled Single Center Trial to Evaluate the Immune Response to the Consumption of a Minidrink Containing a Combination of Lactobacillus GG and Fructooligosaccharides in Patients With Recurrent Herpes Labialis
NCT03307772 is registered in ClinicalTrials.gov with Sprim Advanced Life Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Triple-blind Placebo-controlled Single Center Trial to Evaluate the Immune Response to the Consumption of a Minidrink Containing a Combination of Lactobacillus GG and Fructooligosaccharides in Patients With Recurrent Herpes Labialis
- Lead sponsor
- Sprim Advanced Life Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 15, 2008
- Completion date
- October 20, 2009
- Enrollment
- 78 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.